Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
FDA Approves New Drug to Combat Severe Chronic Eczema
The U.S. Food and Drug Administration approved a new monthly injectable drug that may benefit people with moderate to severe eczema. EBGLYSS, developed by Eli Lilly, offers relief where other therapies have fallen short, potentially helping patients as young as…
English